Deciphera Pharmaceuticals Inc (NQ: DCPH )

47.23 USD +1.27 (+2.76%)

Official Closing Price Updated: 4:01 PM EDT, Apr 15, 2021 Add to My Watchlist

Price and Volume

Volume	293,656
Open	45.92
Bid (Size)	39.22 (1)
Ask (Size)	48.50 (1)
Prev. Close	45.96
Today's Range	45.92 - 47.48
52wk Range	39.42 - 68.40
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

March 31, 2021

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

March 02, 2021

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare...

Performance

YTD	-16.75%	-16.75%
1 Month	+10.51%	+10.51%
3 Month	-8.54%	-8.54%
6 Month	-15.72%	-15.72%
1 Year	+2.12%	+2.12%

More News

Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference

February 18, 2021

Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results

February 09, 2021

Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day

February 04, 2021

Zai Lab's GIST Treatment Approved for China Use

April 02, 2021

We Did The Math JKK Can Go To $346

March 04, 2021

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on February 9, 2021

February 02, 2021

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones

January 11, 2021

Week In Review: Three China In-Licensing Deals Add Up To $662 Million

April 03, 2021

Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 05, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.